Product NDC: | 55390-127 |
Proprietary Name: | Pamidronate Disodium |
Non Proprietary Name: | Pamidronate Disodium |
Active Ingredient(s): | 30 mg/10mL & nbsp; Pamidronate Disodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-127 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075290 |
Marketing Category: | ANDA |
Start Marketing Date: | 20011203 |
Package NDC: | 55390-127-01 |
Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-127-01) > 10 mL in 1 VIAL |
NDC Code | 55390-127-01 |
Proprietary Name | Pamidronate Disodium |
Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-127-01) > 10 mL in 1 VIAL |
Product NDC | 55390-127 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pamidronate Disodium |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20011203 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | PAMIDRONATE DISODIUM |
Strength Number | 30 |
Strength Unit | mg/10mL |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |